JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

Search

KKR & Co LP

Deschisă

SectorFinanțe

113.43 0.23

Rezumat

Modificarea prețului

24h

Curent

Minim

111.62

Maxim

114.01

Indicatori cheie

By Trading Economics

Venit

784M

1.4B

Vânzări

-1.5B

3.2B

P/E

Medie Sector

29.863

20.525

EPS

1.32

Randament dividend

0.71

Marjă de profit

43.254

Angajați

4,834

EBITDA

45M

2.5B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+31.54% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.71%

4.36%

Următoarele câștiguri

1 mai 2025

Următoarea dată ex-dividende

12 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-26B

95B

Deschiderea anterioară

113.2

Închiderea anterioară

113.43

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

KKR & Co LP Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 apr. 2025, 06:50 UTC

Achiziții, Fuziuni, Preluări

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14 apr. 2025, 11:46 UTC

Achiziții, Fuziuni, Preluări

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9 apr. 2025, 10:24 UTC

Achiziții, Fuziuni, Preluări

EQT to Sell Karo Healthcare to KKR

9 apr. 2025, 07:09 UTC

Achiziții, Fuziuni, Preluări

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9 apr. 2025, 06:02 UTC

Achiziții, Fuziuni, Preluări

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7 apr. 2025, 14:42 UTC

Achiziții, Fuziuni, Preluări

Assura Agrees to Primary Health Properties Bid Deadline Extension

4 apr. 2025, 10:15 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 apr. 2025, 09:39 UTC

Achiziții, Fuziuni, Preluări

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

3 apr. 2025, 14:57 UTC

Achiziții, Fuziuni, Preluări

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

3 apr. 2025, 07:17 UTC

Achiziții, Fuziuni, Preluări

Primary Health Proposes $1.95 Billion Bid for Assura

22 apr. 2025, 06:04 UTC

Achiziții, Fuziuni, Preluări

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 apr. 2025, 06:03 UTC

Achiziții, Fuziuni, Preluări

KKR: Biotage Board Recommends Shareholders Accept Offer

22 apr. 2025, 06:02 UTC

Achiziții, Fuziuni, Preluări

KKR: Offer Values Biotage at SEK11.61B

22 apr. 2025, 06:02 UTC

Achiziții, Fuziuni, Preluări

KKR Makes SEK145 a Share Bid For Biotage

18 apr. 2025, 00:00 UTC

Top știri

Private Equity World Engulfed by Perfect Storm -- WSJ

14 apr. 2025, 11:31 UTC

Top știri
Achiziții, Fuziuni, Preluări

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14 apr. 2025, 11:02 UTC

Achiziții, Fuziuni, Preluări

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14 apr. 2025, 11:01 UTC

Achiziții, Fuziuni, Preluări

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14 apr. 2025, 11:00 UTC

Achiziții, Fuziuni, Preluări

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14 apr. 2025, 11:00 UTC

Achiziții, Fuziuni, Preluări

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11 apr. 2025, 11:56 UTC

Achiziții, Fuziuni, Preluări

KKR Now Owns 30% of Enilive

11 apr. 2025, 11:55 UTC

Achiziții, Fuziuni, Preluări

KKR Completes Acquisition of Additional Stake in Enilive

9 apr. 2025, 09:51 UTC

Achiziții, Fuziuni, Preluări

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9 apr. 2025, 09:32 UTC

Achiziții, Fuziuni, Preluări

EQT: Transaction Expected to Close in Coming Months

9 apr. 2025, 09:31 UTC

Achiziții, Fuziuni, Preluări

EQT to Sell Karo Healthcare to KKR

3 apr. 2025, 08:17 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

28 mar. 2025, 09:34 UTC

Achiziții, Fuziuni, Preluări

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

28 mar. 2025, 09:33 UTC

Achiziții, Fuziuni, Preluări

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

28 mar. 2025, 09:31 UTC

Achiziții, Fuziuni, Preluări

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

28 mar. 2025, 09:31 UTC

Achiziții, Fuziuni, Preluări

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Comparație

Modificare preț

KKR & Co LP Așteptări

Obiectiv de preț

By TipRanks

31.54% sus

Prognoză pe 12 luni

Medie 140.5 USD  31.54%

Maxim 194 USD

Minim 114 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruKKR & Co LP - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

11

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

101.87 / N/ASuport & Rezistență

Termen scurt

Very Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m